Two simultaneous procedural earthquakes struck MDL 3092 in the Northern District of Ohio this spring, reshaping the Suboxone lawsuit landscape for thousands of patients who used the dissolvable film strips and suffered devastating tooth decay. The June 1, 2026 census-form deadline has now passed — cases that missed it face real dismissal risk — and a landmark May 2026 court order is forcing thousands of bundled claims to be refiled as individual lawsuits. If you or someone you know took Suboxone sublingual film and experienced severe dental injuries, the next few months may determine whether your case survives at all.
What Is the Suboxone Lawsuit About?
The Suboxone lawsuit targets Indivior and its former parent company Reckitt Benckiser over allegations that the dissolvable sublingual film strips used to treat opioid use disorder contain a highly acidic formulation that erodes tooth enamel, causes severe decay, and leads to tooth loss — all without adequate warning to patients or prescribing physicians. Critically, the claims center on the film strips, not Suboxone tablets, which use a different delivery mechanism.
The litigation gained enormous momentum after the U.S. Food and Drug Administration issued a formal dental safety warning in January 2022, followed by a mandatory label update in June 2022 after hundreds of patient adverse-event reports flooded the agency. The FDA’s own analysis identified 305 dental injury cases directly linked to Suboxone film use, with alarming severity rates across the affected population. If you want a general sense of what these injuries may be worth as personal injury claims, a personal injury settlement calculator can provide a starting framework before you speak with legal counsel.
Core failure-to-warn claims remain active and are the legal backbone of MDL 3092. Earlier rulings narrowed some design-defect arguments, but the failure-to-warn theory — that Indivior and Reckitt Benckiser knew or should have known about the enamel-damaging properties of the acidic film and failed to disclose them — has survived. Daubert hearings on expert testimony concerning those enamel-damaging properties are still pending as of June 2026.
Breaking: The June 1, 2026 Census-Form Deadline and What It Means for Your Case
June 1, 2026 was a hard procedural deadline set by Judge Philip Calabrese of the U.S. District Court for the Northern District of Ohio. Every plaintiff who filed their Suboxone lawsuit before 2025 was required to submit a completed census form by that date. Cases that missed the deadline now face a genuine risk of dismissal — not a theoretical one.
Census forms in mass tort MDLs serve a critical administrative function: they give the court and defendants verified, individual plaintiff data so the litigation can move forward efficiently. When census forms go unfiled, courts treat those cases as inactive or abandoned. Judge Calabrese has shown throughout MDL 3092 that procedural compliance is non-negotiable. If your attorney has not confirmed that your census form was submitted before June 1, 2026, that conversation needs to happen immediately. Because Suboxone dental injuries involve documented medical harm — extractions, crowns, root canals, full dentures — the damages at stake are substantial enough that procedural dismissal would be a preventable tragedy. A medical malpractice calculator can help illustrate the financial scope of defective drug dental injuries like these.
Judge Calabrese’s May 2026 Order: Thousands of Bundled Claims Must Refile
On May 4, 2026, Judge Calabrese issued a landmark procedural ruling that sent ripples through the plaintiff bar: thousands of bundled “Schedule A” claims that were filed together in June 2024 — with multiple plaintiffs grouped under a single complaint — must now be refiled as individual lawsuits or face dismissal. This order directly affects how the docket numbers in MDL 3092 reflect the true scale of the litigation.
As of April 2026, the official docket lists approximately 1,836 cases, but that number is misleading. Because block-filing rules allowed up to 100 plaintiffs per single complaint, the MDL actually involves more than 11,000 individual plaintiffs. The May 2026 order begins the process of converting that mass of grouped filings into individually docketed cases — a procedurally significant shift that affects case management, discovery obligations, and ultimately settlement positioning for each plaintiff. Plaintiffs affected by this order and their attorneys must act quickly; refiling windows in MDL practice are rarely extended, and the court has been explicit about its expectations. You can review general federal civil procedure rules at Cornell Law School’s Legal Information Institute.
The 100-Case Core Discovery Pool and the Road to March 2028 Bellwether Trials
While procedural compliance crises dominate the near-term headlines, the substantive litigation is moving on a locked-in schedule that will define the financial value of every Suboxone lawsuit filed. Here is the precise timeline set by court order:
| Milestone | Date | Detail |
|---|---|---|
| Core Discovery Pool Created | February 26, 2026 | 100 cases selected from initial 500-case pool for intensive discovery |
| 20 Cases Randomly Selected | By June 10, 2026 | Random draw from the 100-case pool to begin bellwether narrowing |
| Parties Identify 15 Preferred Cases | July 2, 2026 | Both sides select preferred bellwether candidates |
| Depositions Complete | January 15, 2027 | Full deposition period closes for bellwether candidates |
| Dispositive Motions Due | March 12, 2027 | Summary judgment and other dispositive motions filed |
| Four Final Bellwether Cases Chosen | June 11, 2027 | Court selects four cases to go to trial |
| First Bellwether Trial | March 2028 | Projected start date for first trial in MDL 3092 |
On February 26, 2026, Judge Calabrese ordered the creation of a 100-case Core Discovery Pool drawn from an initial group of 500 representative cases. These 100 cases are now in intensive discovery — meaning document production, expert reports, and deposition preparation are actively underway. The pool will be narrowed to 15 potential bellwether candidates, then further refined to four final trial cases by June 2027. The first Suboxone lawsuit bellwether trial is projected for March 2028. You can access federal court scheduling orders and procedural filings directly through the federal courts’ official public access portal.
Bellwether trials matter enormously for all 11,000+ plaintiffs, even those whose cases are not among the four selected. Verdicts — whether for plaintiffs or defendants — establish the financial pricing pressure that drives global settlement negotiations. Legal analysts following MDL 3092 project significant settlement payouts once bellwether outcomes give both sides a clear picture of jury valuation for Suboxone dental injuries.
FDA Data: The Documented Scope of Suboxone Dental Harm
The FDA’s own adverse-event database formed the evidentiary foundation that made this litigation viable. Among the 305 dental injury cases the agency identified in connection with Suboxone sublingual film use:
- 37% of patients experienced multi-tooth damage
- 23.3% required tooth extractions — even patients with no prior dental history
- Injuries included severe decay, tooth cracking, erosion, and complete tooth loss
- Many patients required crowns, root canals, bridges, or full dentures
These statistics, drawn from the FDA’s official drug safety communication, underscore why the failure-to-warn claims are so powerful: patients using Suboxone film to treat a serious medical condition had no reason to believe the medication itself was destroying their teeth, and the manufacturers did not warn them before 2022.
Who Qualifies to File a Suboxone Lawsuit?
Eligibility for the Suboxone lawsuit is defined by both product type and injury type. You may qualify if all of the following apply:
- You used Suboxone sublingual film strips (the dissolvable strips placed under the tongue — not Suboxone tablets)
- You developed significant dental injuries during or after use, including severe decay, tooth cracking, erosion, or tooth loss
- You required or will require dental procedures such as extractions, crowns, root canals, bridges, or dentures as a result
- Your dental injuries were not fully explained by pre-existing conditions that would have caused the same outcome independently
Because the litigation involves documented physical harm with measurable medical costs and quality-of-life impacts, damage calculations in these cases can be substantial. In rare cases where patients with extreme health vulnerabilities experienced catastrophic outcomes, families may also explore related legal options — a wrongful death calculator can assist in understanding the financial dimensions of the most severe mass tort scenarios. No global settlement has been announced as of June 2026, meaning the filing window remains open — but with the procedural deadlines already claiming cases, delay carries real risk.
Frequently Asked Questions About the Suboxone Lawsuit
What is the current status of the Suboxone lawsuit MDL in June 2026?
MDL 3092, the Suboxone sublingual film tooth decay litigation, is in an active and high-stakes phase as of June 2026. The June 1, 2026 census-form deadline for pre-2025 filers has passed, and cases that missed it face dismissal risk. A May 4, 2026 court order requires thousands of bundled Schedule A claims to be refiled as individual lawsuits. The 100-case Core Discovery Pool is in intensive discovery, and the first bellwether trial is scheduled for March 2028 before Judge Philip Calabrese in the Northern District of Ohio.
What happens if I missed the June 1, 2026 Suboxone census-form deadline?
Missing the June 1, 2026 census-form deadline puts your Suboxone lawsuit at serious risk of dismissal. Census forms are mandatory procedural documents that verify individual plaintiff information for the court and defendants. If your case was filed before 2025 and the form was not submitted by the deadline, you should contact your attorney immediately to assess whether a motion for relief or other corrective action is available. Courts in MDL proceedings have discretion to dismiss non-compliant cases, and Judge Calabrese has enforced procedural deadlines strictly throughout MDL 3092.
What did Judge Calabrese’s May 2026 order require plaintiffs to do?
On May 4, 2026, Judge Calabrese ruled that thousands of bundled “Schedule A” claims filed in June 2024 — where multiple plaintiffs were grouped into single complaints — must be refiled as individual lawsuits or face dismissal. This order reflects the court’s determination that each plaintiff in the Suboxone lawsuit must be individually docketed for proper case management. Plaintiffs and their attorneys affected by this order must refile within the court’s specified window. Failure to do so risks having those claims dismissed from MDL 3092 entirely.
How do Suboxone sublingual film strips cause tooth damage?
Suboxone sublingual film strips dissolve under the tongue and contain a highly acidic formulation. Prolonged contact between the acidic film and tooth enamel is alleged to cause erosion, severe decay, cracking, and ultimately tooth loss. The FDA identified this mechanism in its January 2022 dental safety warning and required updated product labeling in June 2022 after receiving hundreds of adverse-event reports. The core legal claim in the Suboxone lawsuit is that manufacturers Indivior and Reckitt Benckiser knew or should have known about this dental risk and failed to adequately warn patients and prescribers before 2022.
When will Suboxone lawsuit settlements happen, and how much could cases be worth?
No global settlement in the Suboxone lawsuit has been announced as of June 2026. Settlement negotiations typically intensify after bellwether trial verdicts establish jury valuation of the injuries at stake. With the first bellwether trial projected for March 2028, significant settlement pressure on defendants Indivior and Reckitt Benckiser is expected in late 2027 or 2028 following early verdicts. Individual case values vary based on the severity of dental injuries, treatment costs, loss of income, and pain and suffering — patients who required multiple extractions, implants, or full dentures generally represent the higher end of the damages spectrum.
This content is provided for informational purposes only and does not constitute legal advice or create an attorney-client relationship.
Related reading: Medical Malpractice Damage Caps By State (2026): Complete Data Guide
Related reading: Nursing Home Malpractice Settlement Amounts: 2026 Data, Verdicts & How Compensation Is Calculated
Victoria Chambers is a mass tort and class action research analyst with extensive knowledge of multi-district litigation (MDL), defective product cases, dangerous drug lawsuits, and toxic exposure claims across the United States. Victoria is not an attorney and the information provided is for educational purposes only.